Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Lovastatin | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Lovastatin | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Lovastatin | hsa00190 | Oxidative phosphorylation | 3.52E-04 | 4 | Q16718, Q13488, P36542, O14521 | NDUFA5, TCIRG1, ATP5C1, SDHD | More | | Lovastatin | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Lovastatin | hsa00564 | Glycerophospholipid metabolism | 1.43E-04 | 4 | Q9Y259, P23743, P49619, Q3LIE5 | CHKB, DGKA, DGKG, ADPRM | More | | Lovastatin | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Lovastatin | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Lovastatin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.21E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Lovastatin | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Lovastatin | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Lovastatin | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Lovastatin | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Lovastatin | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Lovastatin | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Lovastatin | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Lovastatin | hsa03013 | RNA transport | 1.89E-08 | 16 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9BZI7, P23588, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, UPF3B, EIF4B, TACC3, FMR1, FXR1 | More | | Lovastatin | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Lovastatin | hsa03040 | Spliceosome | 2.58E-05 | 11 | Q14562, O43143, P08579, O75940, O75494, Q07955, Q01130, P84103, Q13243, P11142, O75643 | DHX8, DHX15, SNRPB2, SMNDC1, FUSIP1, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, ASCC3L1 | More | | Lovastatin | hsa03050 | Proteasome | 1.21E-02 | 1 | P28074 | PSMB5 | More | | Lovastatin | hsa04010 | MAPK signaling pathway | 1.53E-02 | 2 | Q9H2K8, Q12933 | TAOK3, TRAF2 | More | | Lovastatin | hsa04012 | ErbB signaling pathway | 3.49E-03 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Lovastatin | hsa04014 | Ras signaling pathway | 3.57E-02 | 6 | P20827, P49767, P17252, P0DP23, P62873, P19174 | EFNA1, VEGFC, PRKCA, CALM1, GNB1, PLCG1 | More | | Lovastatin | hsa04015 | Rap1 signaling pathway | 2.98E-02 | 6 | P20827, P49767, P11215, P0DP23, P17252, P19174 | EFNA1, VEGFC, ITGAM, CALM1, PRKCA, PLCG1 | More | | Lovastatin | hsa04020 | Calcium signaling pathway | 4.81E-02 | 5 | P27987, P17252, P19174, P0DP23, P49767 | ITPKB, PRKCA, PLCG1, CALM1, VEGFC | More | | Lovastatin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Lovastatin | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Lovastatin | hsa04064 | NF-kappa B signaling pathway | 2.49E-03 | 13 | P10415, Q13489, P14778, P29965, P19174, Q04759, Q9UDY8, P06239, Q8WV28, Q13315, P09341, P19875, Q06643 | BCL2, BIRC3, IL1R1, CD40LG, PLCG1, PRKCQ, MALT1, LCK, BLNK, ATM, CXCL1, CXCL2, LTB | More | | Lovastatin | hsa04070 | Phosphatidylinositol signaling system | 1.01E-04 | 7 | P19174, P0DP23, Q14643, P23743, P49619, P27987, P17252 | PLCG1, CALM1, ITPR1, DGKA, DGKG, ITPKB, PRKCA | More | | Lovastatin | hsa04071 | Sphingolipid signaling pathway | 2.56E-04 | 9 | P17252, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2, Q12933, Q02156 | PRKCA, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2, TRAF2, PRKCE | More | | Lovastatin | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Lovastatin | hsa04110 | Cell cycle | 1.44E-02 | 7 | P06493, O75293, P30304, P33981, P42773, P01106, Q13547 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC, HDAC1 | More | | Lovastatin | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Lovastatin | hsa04145 | Phagosome | 1.59E-03 | 7 | Q15080, P14598, Q13509, P68371, Q13488, O60603, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2, HLA-DOB | More | | Lovastatin | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Lovastatin | hsa04151 | PI3K-Akt signaling pathway | 4.50E-02 | 9 | P25116, P49767, Q13362, P62873, P16144, O60603, P01568, P10415, P17252 | F2R, VEGFC, PPP2R5C, GNB1, ITGB4, TLR2, IFNA21, BCL2, PRKCA | More | | Lovastatin | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Lovastatin | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Lovastatin | hsa04217 | Necroptosis | 9.14E-03 | 7 | P01568, Q13489, P42224, Q6FI13, P10415, O43633, Q08752 | IFNA21, BIRC3, STAT1, H2AC18; H2AC19, BCL2, CHMP2A, PPID | More | | Lovastatin | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.84E-02 | 5 | P09493, Q13362, P0DP23, P17252, P10415 | TPM1, PPP2R5C, CALM1, PRKCA, BCL2 | More | | Lovastatin | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Lovastatin | hsa04360 | Axon guidance | 1.53E-02 | 5 | P16333, P20827, O95631, P17252, P19174 | NCK1, EFNA1, NTN1, PRKCA, PLCG1 | More | | Lovastatin | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Lovastatin | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Lovastatin | hsa04613 | Neutrophil extracellular trap formation | 2.78E-04 | 13 | P19174, P17252, P11215, O60603, P08246, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P21462 | PLCG1, PRKCA, ITGAM, TLR2, ELA2, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, FPR1 | More | | Lovastatin | hsa04622 | RIG-I-like receptor signaling pathway | 2.47E-02 | 1 | Q12933 | TRAF2 | More | | Lovastatin | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Lovastatin | hsa04650 | Natural killer cell mediated cytotoxicity | 2.48E-03 | 8 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3 | More | | Lovastatin | hsa04657 | IL-17 signaling pathway | 1.95E-03 | 8 | P25963, P08238, Q07955, P49841, P14780, P04141, P01375, P06702 | NFKBIA, HSP90AB1, SFRS1, GSK3B, MMP9, CSF2, TNF, S100A9 | More | | Lovastatin | hsa04658 | Th1 and Th2 cell differentiation | 1.30E-09 | 12 | P25963, Q04759, P07766, P20963, P19174, P01730, P06239, P42224, Q9UL17, P14784, Q9UM47, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, PLCG1, CD4, LCK, STAT1, TBX21, IL2RB, NOTCH3, RUNX3 | More | | Lovastatin | hsa04659 | Th17 cell differentiation | 7.18E-07 | 12 | P25963, Q04759, P19174, P01730, P06239, P42224, P14784, P14778, Q9UL17, P08238, P07766, P20963 | NFKBIA, PRKCQ, PLCG1, CD4, LCK, STAT1, IL2RB, IL1R1, TBX21, HSP90AB1, CD3E, CD247 | More | | Lovastatin | hsa04660 | T cell receptor signaling pathway | 4.50E-04 | 10 | Q04759, P42338, P19174, P16333, P07766, P20963, P01730, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, NCK1, CD3E, CD247, CD4, CD8A, CBLB, LCK | More | | Lovastatin | hsa04664 | Fc epsilon RI signaling pathway | 4.75E-02 | 3 | P07948, P19174, P09917 | LYN, PLCG1, ALOX5 | More | | Lovastatin | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Lovastatin | hsa04713 | Circadian entrainment | 2.60E-02 | 4 | P0DP23, P17252, P62873, Q14643 | CALM1, PRKCA, GNB1, ITPR1 | More | | Lovastatin | hsa04720 | Long-term potentiation | 3.89E-02 | 3 | P17252, P0DP23, Q14643 | PRKCA, CALM1, ITPR1 | More | | Lovastatin | hsa04722 | Neurotrophin signaling pathway | 9.39E-03 | 2 | Q05655, P52566 | PRKCD, ARHGDIB | More | | Lovastatin | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Lovastatin | hsa04725 | Cholinergic synapse | 1.88E-02 | 4 | Q14643, P17252, P62873, P10415 | ITPR1, PRKCA, GNB1, BCL2 | More | | Lovastatin | hsa04727 | GABAergic synapse | 3.40E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Lovastatin | hsa04728 | Dopaminergic synapse | 3.55E-02 | 5 | Q14643, P17252, P62873, Q13362, P0DP23 | ITPR1, PRKCA, GNB1, PPP2R5C, CALM1 | More | | Lovastatin | hsa04744 | Phototransduction | 9.81E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Lovastatin | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Lovastatin | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Lovastatin | hsa04912 | GnRH signaling pathway | 3.89E-02 | 3 | P17252, Q14643, P0DP23 | PRKCA, ITPR1, CALM1 | More | | Lovastatin | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Lovastatin | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Lovastatin | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Lovastatin | hsa04924 | Renin secretion | 8.71E-03 | 3 | Q14643, Q13370, P0DP23 | ITPR1, PDE3B, CALM1 | More | | Lovastatin | hsa04930 | Type II diabetes mellitus | 9.83E-04 | 2 | Q05655, Q02156 | PRKCD, PRKCE | More | | Lovastatin | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Lovastatin | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.27E-02 | 5 | P42224, P10415, Q12778, P49767, P17252 | STAT1, BCL2, FOXO1, VEGFC, PRKCA | More | | Lovastatin | hsa04966 | Collecting duct acid secretion | 2.86E-02 | 2 | Q13488, Q9Y666 | TCIRG1, SLC12A7 | More | | Lovastatin | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Lovastatin | hsa04974 | Protein digestion and absorption | 2.47E-02 | 1 | Q7Z2H8 | SLC36A1 | More | | Lovastatin | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Lovastatin | hsa05010 | Alzheimer disease | 3.55E-02 | 7 | Q16718, O14521, Q14643, P0DP23, Q13509, P68371, Q08752 | NDUFA5, SDHD, ITPR1, CALM1, TUBB3, TUBB2C, PPID | More | | Lovastatin | hsa05012 | Parkinson disease | 2.25E-02 | 6 | Q16718, O14521, Q14643, P0DP23, Q13509, P68371 | NDUFA5, SDHD, ITPR1, CALM1, TUBB3, TUBB2C | More | | Lovastatin | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Lovastatin | hsa05017 | Spinocerebellar ataxia | 2.43E-02 | 1 | P28074 | PSMB5 | More | | Lovastatin | hsa05020 | Prion disease | 1.15E-02 | 7 | Q16718, O14521, Q14643, Q13509, P68371, P14598, Q15080 | NDUFA5, SDHD, ITPR1, TUBB3, TUBB2C, NCF1, NCF4 | More | | Lovastatin | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.48E-03 | 10 | Q14643, Q13509, P68371, P10415, Q16718, O14521, Q13561, P17252, Q08752, P0DP23 | ITPR1, TUBB3, TUBB2C, BCL2, NDUFA5, SDHD, DCTN2, PRKCA, PPID, CALM1 | More | | Lovastatin | hsa05034 | Alcoholism | 1.90E-05 | 9 | Q13547, P0DP23, P62873, P63218, P50151, Q93077, P62807, O60814, P68431 | HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Lovastatin | hsa05110 | Vibrio cholerae infection | 1.51E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Lovastatin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Lovastatin | hsa05131 | Shigellosis | 4.98E-04 | 12 | Q12933, P68431, Q05655, Q02156, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752, P07737 | TRAF2, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCD, PRKCE, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID, PFN1 | More | | Lovastatin | hsa05132 | Salmonella infection | 6.68E-03 | 10 | Q9UJU2, P84095, Q13489, P10415, P07737, O60603, Q9BQS8, Q13561, Q13509, P68371 | LEF1, RHOG, BIRC3, BCL2, PFN1, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Lovastatin | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Lovastatin | hsa05140 | Leishmaniasis | 7.47E-05 | 8 | P14598, P11215, P42224, P13765, O60603, P25963, P29350, Q15080 | NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, PTPN6, NCF4 | More | | Lovastatin | hsa05145 | Toxoplasmosis | 1.16E-03 | 10 | P10415, Q13489, P42224, P13765, P09917, Q13751, P11142, O60603, P29965, Q13651 | BCL2, BIRC3, STAT1, HLA-DOB, ALOX5, LAMB3, HSPA8, TLR2, CD40LG, IL10RA | More | | Lovastatin | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | | Lovastatin | hsa05150 | Staphylococcus aureus infection | 4.02E-03 | 6 | P21462, O75015, Q14532, P59665, P59666, P12838 | FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Lovastatin | hsa05152 | Tuberculosis | 7.93E-04 | 8 | Q13488, P0DP23, P42224, O60603, P10415, P13765, P01568, Q9UDY8 | TCIRG1, CALM1, STAT1, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Lovastatin | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Lovastatin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 6.61E-04 | 13 | P01568, P42224, P25963, P62873, P63218, P50151, P19174, Q14643, P07948, P01106, P04141, P0DP23, Q9UJU2 | IFNA21, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, ITPR1, LYN, MYC, CSF2, CALM1, LEF1 | More | | Lovastatin | hsa05168 | Herpes simplex virus 1 infection | 4.39E-02 | 9 | P25963, P42224, Q07955, Q01130, Q13243, Q13398, Q03923, O75820, Q9UDV6 | NFKBIA, STAT1, SFRS1, SFRS2, SFRS5, ZNF211, ZNF85, ZNF189, ZNF212 | More | | Lovastatin | hsa05169 | Epstein-Barr virus infection | 1.43E-02 | 8 | P01106, Q13547, P07948, P30101, Q13761, O75293, P42224, P07766 | MYC, HDAC1, LYN, PDIA3, RUNX3, GADD45B, STAT1, CD3E | More | | Lovastatin | hsa05170 | Human immunodeficiency virus 1 infection | 4.67E-03 | 9 | P62873, P0DP23, P17252, Q14643, P01568, O60603, Q13315, P10415, Q9Y6Q5 | GNB1, CALM1, PRKCA, ITPR1, IFNA21, TLR2, ATM, BCL2, AP1M2 | More | | Lovastatin | hsa05200 | Pathways in cancer | 1.76E-04 | 26 | Q13751, P08238, P42224, P25963, P19174, P01106, Q9UJU2, P17252, P43246, P20585, Q13547, P14923, P10415, Q13489, P49767, Q12778, P25116, P62873, P63218, P50151, Q9UM47, P78417, O75293, P0DP23, P01568, P14784 | LAMB3, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, LEF1, PRKCA, MSH2, MSH3, HDAC1, JUP, BCL2, BIRC3, VEGFC, FOXO1, F2R, GNB1, GNG5, GNG10, NOTCH3, GSTO1, GADD45B, CALM1, IFNA21, IL2RB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11215 | ITGAM | Integrin alpha-M | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.779 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.783 | P11215 | ITGAM | Integrin alpha-M | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.78 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 1 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P11215 | ITGAM | Integrin alpha-M | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.844 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.734 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.851 | P11215 | ITGAM | Integrin alpha-M | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.913 | P11215 | ITGAM | Integrin alpha-M | P01106 | MYC | Myc proto-oncogene protein | -0.743 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P17252 | PRKCA | Protein kinase C alpha type | -0.706 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.789 | P11215 | ITGAM | Integrin alpha-M | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.712 | P11215 | ITGAM | Integrin alpha-M | P20585 | MSH3 | DNA mismatch repair protein Msh3 | -0.703 | P11215 | ITGAM | Integrin alpha-M | Q13547 | HDAC1 | Histone deacetylase 1 | -0.751 | P17252 | PRKCA | Protein kinase C alpha type | P14923 | JUP | Junction plakoglobin | 0.761 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P49767 | VEGFC | Vascular endothelial growth factor C | -0.754 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P11215 | ITGAM | Integrin alpha-M | P49767 | VEGFC | Vascular endothelial growth factor C | 0.711 | P17252 | PRKCA | Protein kinase C alpha type | Q12778 | FOXO1 | Forkhead box protein O1 | 0.863 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.84 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P11215 | ITGAM | Integrin alpha-M | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.819 | P11215 | ITGAM | Integrin alpha-M | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.746 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | 0.714 | P11215 | ITGAM | Integrin alpha-M | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.728 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.802 | P11215 | ITGAM | Integrin alpha-M | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.712 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.732 | P11215 | ITGAM | Integrin alpha-M | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.769 |
| Lovastatin | hsa05203 | Viral carcinogenesis | 6.58E-03 | 7 | P07948, P29083, Q13547, Q15283, P12814, P62807, O60814 | LYN, GTF2E1, HDAC1, RASA2, ACTN1, HIST1H2BC, H2BC12 | More | | Lovastatin | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Lovastatin | hsa05206 | MicroRNAs in cancer | 4.49E-03 | 9 | P30304, P09493, P01106, Q9Y4H2, Q9UM47, Q13547, P20827, P17252, P19174 | CDC25A, TPM1, MYC, IRS2, NOTCH3, HDAC1, EFNA1, PRKCA, PLCG1 | More | | Lovastatin | hsa05214 | Glioma | 7.66E-03 | 4 | P0DP23, P17252, P19174, O75293 | CALM1, PRKCA, PLCG1, GADD45B | More | | Lovastatin | hsa05223 | Non-small cell lung cancer | 4.24E-02 | 3 | P19174, Q9HC35, O75293 | PLCG1, EML4, GADD45B | More | | Lovastatin | hsa05231 | Choline metabolism in cancer | 5.78E-06 | 6 | O15245, Q9Y259, P19174, P23743, P49619, P17252 | SLC22A1, CHKB, PLCG1, DGKA, DGKG, PRKCA | More | | Lovastatin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.41E-05 | 9 | P42338, P19174, P07766, P20963, P06239, P42224, Q04759, Q9HC35, P01730 | PIK3CB, PLCG1, CD3E, CD247, LCK, STAT1, PRKCQ, EML4, CD4 | More | | Lovastatin | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Lovastatin | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 10 | P08246, P09871, P10747, P13765, P29965, Q6FI13, Q93077, P62807, O60814, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Lovastatin | hsa05323 | Rheumatoid arthritis | 1.29E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | Lovastatin | hsa05330 | Allograft rejection | 1.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Lovastatin | hsa05340 | Primary immunodeficiency | 4.24E-02 | 3 | P01730, P07766, P06239 | CD4, CD3E, LCK | More | | Lovastatin | hsa05415 | Diabetic cardiomyopathy | 3.55E-02 | 5 | P17252, P14598, Q15080, Q16718, O14521 | PRKCA, NCF1, NCF4, NDUFA5, SDHD | More | | Lovastatin | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | |